Neurology

You are here

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Full Title: 
Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (subcutaneous immunoglobulin) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) - the PATH study Protocol IgPro20_3003

Specialty: 

Status: 

Principle Investigator: 
Norman Latov, MD, PhD
Contact Phone : 
(646) 962-2149
Additional Cornell Investigator: 
Russell L. Chin, MD Jennifer A. Langsdorf, MD

To read more about this study visit the ClinicalTrials.gov page here.

Weill Cornell Medicine Neurology 520 East 70th Street (at York Avenue) Starr Pavilion 607 New York, NY 10021 Phone: (212) 746-2596